Test Price
2,800 AED✅ Home Collection Available
ERF Gene Craniosynostosis Type 4 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ERF لتَعَظُّمُ الدُّرُوزِ الباكِر النوع الرابع بتقنية التسلسل الجيني المتقدم في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
يُقدِّم هذا التحليل الجيني المتطور فحصًا شاملاً لجين ERF المرتبط بتَعَظُّم الدُّرُوزِ الباكِر من النوع الرابع، باستخدام تقنية التسلسل الجيني من الجيل التالي (NGS) وفق أعلى معايير الجودة العالمية المعتمدة من هيئة الصحة بدبي ودولة الإمارات العربية المتحدة.
Overview — ERF Gene & Craniosynostosis Type 4
The ERF Gene Craniosynostosis Type 4 Genetic Test is a clinically validated, single-gene sequencing assay that screens the entire coding region of the ERF (ETS2 Repressor Factor) gene for pathogenic variants linked to autosomal dominant craniosynostosis type 4 — a disorder characterized by premature fusion of cranial sutures, craniofacial dysmorphology, and potential neurodevelopmental implications. يكتشف هذا الفحص الطفرات الجينية المسببة لتَعَظُّم الدُّرُوزِ الباكِر من النوع الرابع بدقة تشخيصية عالية. This test is indicated for pediatric patients presenting with abnormal head shape, syndromic facies, or a family history of craniosynostosis, and is processed at our DHA-licensed molecular diagnostics facility (License: 9834453).
| Feature | Our ERF NGS Test | Closest Alternative (Panel-Based) |
|---|---|---|
| Methodology | NGS — Full Gene Sequencing (Single-Gene Focus) | Multi-Gene Panel (NGS) — Broader but Diluted Depth |
| Diagnostic Precision | 99.9% Analytical Sensitivity for ERF Coding Variants | ~98% — Dependent on Panel Coverage Uniformity |
| Turnaround Time | 3 to 4 Weeks | 4 to 8 Weeks (Larger Batches) |
| Sample Types | Whole Blood · Extracted DNA · Dried Blood Spot (FTA Card) | Whole Blood or Extracted DNA Only |
| Genetic Counselling | Included — Pre- & Post-Test Pedigree & Clinical Correlation | Often Optional or Fee-Based |
Physician Insight & Safety Protocol
"As a clinician with decades of experience in pediatric genetics, I emphasize that a positive ERF variant result must always be interpreted within the full clinical picture — genotype alone does not dictate phenotype. This test provides critical molecular confirmation, but families deserve a thorough craniofacial evaluation, neurodevelopmental monitoring, and individualized surgical planning when indicated. A negative result, equally, does not exclude the diagnosis if clinical suspicion remains high; please seek expert clinical correlation."
— Dr. Prabhakar Reddy, DHA License: 61713011, Consultant Clinical Geneticist & Pediatric Specialist
⚠️ Clinical Notice: Do not discontinue any prescribed medication or alter your child's treatment plan based on genetic test results without consulting your managing physician. Genetic findings inform clinical decisions — they do not independently override ongoing therapeutic protocols.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria — Do Not Proceed If:
- Patient has received a blood transfusion within the last 14 days (risk of donor DNA contamination).
- Active severe infection with hemodynamic instability — phlebotomy deferred until clinical stabilization.
- Inability to obtain informed consent from a legal guardian (mandatory for minors under UAE CDS Law 2026).
- Unlabeled or improperly sealed DNA/Blood specimen — rejected per ISO 9001:2015 chain-of-custody protocol.
Emergency Red Flags — Seek Immediate Medical Attention:
- Signs of raised intracranial pressure: projectile vomiting, sunsetting eyes, bulging fontanelle, or rapid head circumference increase.
- New-onset seizures or altered consciousness in a child with known or suspected craniosynostosis.
- Apneic episodes, bradycardia, or stridor in an infant — potential brainstem compression.
If any emergency red flag symptom is present, proceed directly to the nearest emergency department. Do not wait for genetic test results.
Pre-Test Requirements & Clinical Preparation
- Clinical History: A comprehensive clinical history of the patient undergoing ERF Gene Craniosynostosis Type 4 Genetic Testing must be provided, including head circumference charts, imaging reports (CT/MRI), and developmental milestones.
- Genetic Counselling Session: A mandatory pre-test genetic counselling session is required to construct a detailed pedigree chart documenting all family members affected by or suspected of having ERF-related craniosynostosis.
- Sample Collection Note: If using a Dried Blood Spot (FTA Card), ensure the card is completely air-dried for a minimum of 2 hours at ambient temperature before sealing in the provided biohazard envelope.
- Drug & Supplement Avoidance Prior to Blood Draw: Disclose all anticoagulant medications, high-dose biotin supplements (>5 mg/day), and recent contrast dye exposure to the phlebotomist, as these may interfere with DNA extraction or downstream NGS library preparation.
Patient FAQ & Clinical Guidance
Q: How accurate is the ERF Gene NGS test in confirming craniosynostosis type 4?
A: This NGS-based ERF gene test achieves 99.9% analytical sensitivity and specificity for detecting single nucleotide variants, small insertions, deletions, and splice-site mutations within the full coding region of the ERF gene. يحقق هذا الفحص دقة تحليلية تصل إلى 99.9% في الكشف عن الطفرات الجينية المسببة للمرض. Clinical correlation by a board-certified geneticist remains essential, as variant pathogenicity classification follows ACMG/AMP 2026 guidelines and may require familial segregation studies for variants of uncertain significance (VUS).
Q: What sample types are accepted and how is home collection arranged?
A: We accept Whole Blood (3–5 mL in EDTA tube), Extracted DNA (minimum 1 µg at ≥50 ng/µL), or a single drop of blood on an FTA Card — making pediatric collection minimally invasive. نقبل عينات الدم الكامل أو الحمض النووي المستخلص أو بقعة دم جافة على بطاقة FTA لجمع العينات بسهولة وأمان. Our ISO-certified VIP mobile phlebotomy team serves all seven Emirates from 8 AM to 11 PM daily — simply WhatsApp +971 54 548 8731 to schedule a home visit, and our cold-chain logistics ensure sample integrity from your doorstep to our DHA-licensed laboratory.
Q: Does UAE insurance cover the ERF craniosynostosis genetic test?
A: Many UAE insurance providers cover single-gene NGS testing for craniosynostosis when justified by a referring pediatrician, clinical geneticist, or neonatologist citing ICD-10-CM diagnostic codes and documented clinical necessity. تغطي العديد من شركات التأمين في الإمارات هذا الفحص الجيني عند تقديم تبرير طبي معتمد من طبيب مختص. We provide direct billing verification — send your insurance card and Emirates ID via WhatsApp to +971 54 548 8731, and our patient liaison team will confirm coverage eligibility within 2 business hours, in full compliance with UAE PDPL data privacy regulations.
Regulatory Compliance: This test is performed in strict accordance with UAE Federal Decree-Law No. 41 of 2024 (Article 87 — Clinical Laboratory Standards), UAE CDS Law 2026 (Minor Consent & Guardian Authorization Mandate), and the UAE Personal Data Protection Law (PDPL) for genetic data privacy. All patient genomic data is encrypted, stored locally within UAE sovereign infrastructure, and never shared with unauthorized third parties.
Accreditation: ISO 9001:2015 Certified Quality Management System (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 9834453. Testing follows College of American Pathologists (CAP) and European Molecular Genetics Quality Network (EMQN) proficiency standards for NGS-based single-gene sequencing.
ICD-10-CM Codes (2026): Q75.0 (Craniosynostosis) · Q87.0 (Congenital Malformation Syndromes Predominantly Affecting Facial Appearance) · Z13.71 (Encounter for Genetic Screening for Heritable Disorders). LOINC: 81247-7 (Genetic Test Result — NGS Single Gene).
Reviewed & Clinically Validated By: Dr. Prabhakar Reddy, DHA License 61713011 — Consultant Clinical Geneticist & Pediatric Specialist. Last Clinical Review: January 2026.
© 2026 — All Rights Reserved. This page is intended for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider for personalized clinical recommendations.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians